NEWS

TEL AVIV, Israel and BETHESDA, Maryland, Oct. 25, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

TEL AVIV, Israel and BETHESDA, Maryland, Oct. 19, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

TEL AVIV, Israel and BETHESDA, Maryland, Oct. 16, 2018 /PRNewswire/ --  Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabi

TEL AVIV, Israel and BETHESDA, Maryland, Oct. 9, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabino

TEL AVIV, Israel and BETHESDA, Maryland, September 24, 2018 /PRNewswire/ -- CANNABICS PHARMACEUTICALS INC. (OTCQB: CNBX) ("Cannabics" or the 

TEL AVIV, Israel and BETHESDA, Maryland, Sept. 21, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized can

TEL AVIV, Israel and BETHESDA, Maryland, Sept. 18, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a leader in personalized cannabino

TEL AVIV, Israel and BETHESDA, Maryland, Sept. 14, 2018 /PRNewswire/ --  Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannab

TEL AVIV, Israel and BETHESDA, Maryland, Sept. 5, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

TEL AVIV, Israel, August 28, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine

Aug. 22, 2018, TEL AVIV, Israel and BETHESDA, Maryland /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

TEL AVIV, Israel and BETHESDA, Maryland, Aug. 14, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

TEL AVIV, Israel and BETHESDA, Maryland, Aug. 10, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

TEL AVIV, Israel and BETHESDA, Maryland, August 9, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabi

TEL AVIV, Israel and BETHESDA, Maryland, Aug. 2, 2018 /PRNewswire/ -- Dear Fellow Shareholders, I am pleased to announce that we have ente

TEL AVIV, Israel and BETHESDA, Maryland, July 11, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

TEL AVIV, Israel and BETHESDA, Maryland, July 3, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), leader in personalized cannabi

TEL AVIV, Israel and BETHESDA, Maryland, June 29, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabis

TEL AVIV, Israel and BETHESDA, Maryland, June 26, 2018 /PRNewswire/ --  Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabi

TEL AVIV, Israel and BETHESDA, Maryland, May 24, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals (OTCQB: CNBX), a US bio-pharma company develo

TEL AVIV, Israel and BETHESDA, Maryland, May 22, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), leader in cannabinoid diagnostic tests fo

TEL AVIV, Israel and BETHESDA, Maryland, May 2, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), leader in cannabinoid diagnostic

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in cannabinoid diagnostics for the personalized treatment of cancer, today announced the receip

TEL AVIV, Israel and BETHESDA, Maryland, March 29, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), a leader in cannabinoid diagno

TEL AVIV, Israel, February 28, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) announced today that Dr. Moran Grinberg, VP

TEL AVIV, Israel and BETHESDA, Maryland, February 20, 2018 Cannabics Pharmaceuticals Inc. (CNBX), a US public biotechnology company dedicated

TEL-AVIV, Israel, January 2, 2018 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has filed an international patent appl

TEL-AVIV, Israel, November 8, 2017 Cannabics Pharmaceuticals Inc. (CNBX) announced today that it has filed the first of a cluster of patent a

TEL AVIV, Israel, September 25, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) today announced it has filed national phase patent a

TEL-AVIV, Israel, September 6, 2017 Cannabics Pharmaceuticals Inc. (CNBX) announced today that it has filed an extensive provisional patent a

TEL-AVIV, Israel, August 28, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) (OTCQB: CNBX) today announced it received a very positive prel

Cannabics Pharmaceuticals Inc. (OTC-QB: CNBX) today announced it has established a Genetic lab that will develop diagnostic tools based on human genom

Cannabics Pharmaceuticals Inc. (CNBX) today announced it has executed a Collaboration Agreement with SIMFO GmbH, a world leader in cancer diagnostics

Cannabics Pharmaceuticals Inc. (CNBX) today announced it received positive results from screening necrosis (cell death) of circulating tumor cells, fr

Cannabics Pharmaceuticals Inc. (OTC-QB: CNBX) today Provides Shareholders Update for June 2017: Cannabis has the potential of being a natural

Cannabics Pharmaceuticals Inc. (CNBX) today announced it has entered into a securities purchase agreement with D-Beta One EQ, Ltd. ("D-Beta"). D-Beta

TEL AVIV, Israel, May 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced it has begun a scientific collaboration with a med

TEL AVIV, Israel, April 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) is pleased to announce that it received the final report of the

Cannabics' Pharmaceutical (CNBX) Board of Directors is proud to announce its addition of several highly-respected professionals to its Board of Adviso

BETHESDA, Maryland, Feb. 23, 2017 /PRNewswire/ -- The management of Cannabics Pharmaceuticals Inc. (CNBX) wishes to inform its shareholders and public